BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
